Gardasil for boys is not cost-effective, study says

10/9/2009 | Los Angeles Times (tiered subscription model)

A government campaign to give boys Gardasil, a cervical cancer vaccine that protects against human papillomavirus, would be no more effective in reducing HPV-related diseases and cost much more than a vaccination campaign directed at girls, Harvard University researchers concluded. The findings come as the FDA considers allowing boys to receive Gardasil, made by Merck & Co.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN